CCL1: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 32: | Line 32: | ||
[[Category:Medical terms]] | [[Category:Medical terms]] | ||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
{{No image}} | |||
Revision as of 08:58, 10 February 2025
CCL1 is a small cytokine belonging to the CC chemokine family that is also known as TCA3 (T cell activation gene 3). CCL1 is expressed predominantly by T cells of the immune system, and attracts certain cells of the immune system, including monocytes, and dendritic cells. This chemokine is secreted in a glycosylated form from cells stimulated with the inflammatory cytokines interleukin-1 or tumor necrosis factor-alpha.
Function
CCL1 elicits its effects on cells by binding to a cell surface chemokine receptor known as CCR8. This gene is located on chromosome 17 in humans, in a large cluster of other CC chemokines.
Clinical significance
CCL1 has been implicated in immunoregulatory and inflammatory processes. It is known to play a role in the T cell response and can influence the progression of diseases such as atherosclerosis and cancer.
See also
- Chemokine
- Cytokine
- Monocytes
- Dendritic cells
- Interleukin-1
- Tumor necrosis factor-alpha
- CCR8
- Atherosclerosis
- Cancer
References
<references />


